Research  >  Research  >  Research platforms  >  Evaluative Clinical Sciences  >  Scientists
PAGE
MENU

Evaluative Clinical Sciences

SRI platforms

Dr. Maneesh Sud
Maneesh Sud, MD PhD

Clinician-scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave.
Toronto, ON
M4N 3M5

Phone: 416-480-6066
Fax: 416-480-6174

Administrative Assistant, (Clinical): Nita Dalal-Weber
Phone: 416-480-6066
Email: nita.dalalweber@sunnybrook.ca

Senior Administrative Assistant, Schulich Heart Research Program: Tasneem Dalal
Phone: 416-480-4975
Email: tasneem.dalal@sri.utoronto.ca

Education:

  • BSc, 2007, University of Toronto, Canada
  • MD, 2011, University of Manitoba, Canada
  • Residency, 2014, Internal Medicine, University of Toronto, Canada
  • Fellowship, 2017, Cardiology, University of Toronto, Canada
  • Fellowship, 2019, Interventional Cardiology, Sunnybrook Health Sciences Centre, Canada
  • PhD, 2023, Institute of Health Policy, Management and Evaluation, University of Toronto, Canada

Appointments and Affiliations:

Research Foci:

  • Cardiovascular Health Outcomes Research
  • Primary and Secondary Prevention
  • Cardiac catheterization and percutaneous coronary interventions

Research Summary:

Dr. Sud’s research focuses on identifying care gaps and developing innovative solutions to improve the delivery of evidence-based treatments across the spectrum of patients with coronary artery disease.

Selected Publications:

See current publications list at PubMed

  1. Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease. Sud M, Sivaswamy A, Austin PC, Anderson TJ, Naimark DMJ, Farkouh ME, Lee DS, Roifman I, Thanassoulis G, Tu K, Udell JA, Wijeysundera HC, Ko DT. Ann Intern Med. 2023 Dec;176(12):1638-1647.
  2. Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations. Sud M, Sivaswamy A, Chu A, Austin PC, Anderson TJ, Naimark DMJ, Farkouh ME, Lee DS, Roifman I, Thanassoulis G, Tu K, Udell JA, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2022 Oct 4;80(14):1330-1342.
  3. Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease. Sud M, Han L, Koh M, Austin PC, Farkouh ME, Ly HQ, Madan M, Natarajan MK, So DY, Wijeysundera HC, Fang J, Ko DT. JAMA. 2020 Dec 15;324(23):2406-2414.
  4. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention. Sud M, Han L, Koh M, Abdel-Qadir H, Austin PC, Farkouh ME, Godoy LC, Lawler PR, Udell JA, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2020 Sep 22;76(12):1440-1450.
  5. Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease. Sud M, Tangri N, Pintilie M, Levey AS, Naimark D. Circulation. 2014 Aug 5;130(6):458-65.

Related Links: